What is the recommended oral loading dose of amiodarone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Oral Loading Dose of Amiodarone

The recommended oral loading dose of amiodarone is 400-600 mg daily in divided doses for 2-4 weeks, followed by a maintenance dose of 100-200 mg daily. 1

Initial Loading Dose Regimen

  • For ventricular arrhythmias, start with 800-1600 mg per day in divided doses until a total of 10 g has been administered, then transition to maintenance therapy of 200-400 mg per day 1, 2
  • For atrial fibrillation, use 600-800 mg per day in divided doses until a total of 10 g has been given, then reduce to a maintenance dose of 200 mg per day 1, 2
  • Higher initial loading doses (up to 1200 mg daily) may be considered in an inpatient monitoring setting, though this increases the risk of adverse effects 1

Alternative Loading Protocols

  • Some clinicians use a more aggressive loading approach of 50 mg/kg per day for 3 days, followed by 30 mg/kg per day for 2 days, then maintenance therapy of 300-400 mg twice daily 3
  • Another approach is 800 mg/day for 6 weeks followed by 600 mg/day maintenance, though this higher maintenance dose is associated with significant toxicity in approximately 50% of patients 4
  • A single oral loading dose of 25-30 mg/kg has been used for recent-onset atrial tachyarrhythmias with a 64.4% success rate for conversion to sinus rhythm within 24 hours 5

Important Considerations

  • Monitoring is essential during loading: Watch for bradycardia, QT prolongation, hypotension, and heart block 1, 2
  • Amiodarone has a very long half-life, and the full antiarrhythmic effect may take days to weeks to develop despite adequate serum levels 2
  • The dose should be reduced if side effects occur; in one study, the dose was reduced from 572 ± 283 mg per day at 45 days to 372 ± 174 mg per day at 6 months due to adverse effects 6
  • Side effects are common (occurring in up to 93% of patients), with gastrointestinal effects, corneal microdeposits, neurologic effects (tremor, ataxia), and pulmonary toxicity being most concerning 6

Transitioning from IV to Oral Amiodarone

  • For patients receiving IV amiodarone for less than one week, transition to 800-1600 mg oral amiodarone per day 1, 2
  • For patients receiving IV amiodarone for 1-3 weeks, transition to 600-800 mg oral amiodarone per day 2
  • For patients receiving IV amiodarone for more than 3 weeks, transition to 400 mg oral amiodarone per day 2

Pitfalls to Avoid

  • Do not drink grapefruit juice during treatment with oral amiodarone as it inhibits CYP3A-mediated metabolism, resulting in increased plasma levels 7
  • Be aware of significant drug interactions, particularly with warfarin (reduce warfarin dose by 50%) and digoxin (reduce digoxin dose by 30-50%) 1
  • Avoid coadministration with other QT-prolonging medications without expert consultation 1
  • Monitor for pulmonary toxicity, thyroid dysfunction, and hepatic toxicity during long-term therapy 1

By following these guidelines, the oral loading dose of amiodarone can be safely administered to achieve therapeutic effects while minimizing the risk of adverse events.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiodarone Oral to Intravenous Equivalency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

High dose oral amiodarone loading: electrophysiologic effects and clinical tolerance.

Journal of the American College of Cardiology, 1992

Research

Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.

Journal of the American College of Cardiology, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.